Qilu Pharmaceutical competitive analysis

Explore patent oppositions filed by Qilu Pharmaceutical against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALSAug 25, 2026

Latest PTAB cases involving Qilu Pharmaceutical

Discover the latest PTAB cases involving Qilu Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Qilu Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
QILU PHARMACEUTICAL1 - - -
REGENERON PHARMACEUTICALS39141932